As regards to the localization of venous thrombosis among ET patients, 20% of the ET patients with high JAK2V617F allele burden experienced deep vein thrombosis (DVT) whereas the frequency of DVT was 2.3% in patients with wild-type JAK2. Here, JAK2 is linked to essential thrombocythemia.